nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.282	1	CbGaD
Hydrocodone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0425	0.101	CbGbCtD
Hydrocodone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0419	0.0998	CbGbCtD
Hydrocodone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0392	0.0934	CbGbCtD
Hydrocodone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0373	0.089	CbGbCtD
Hydrocodone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0341	0.0814	CbGbCtD
Hydrocodone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0322	0.0767	CbGbCtD
Hydrocodone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0308	0.0735	CbGbCtD
Hydrocodone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0298	0.0711	CbGbCtD
Hydrocodone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.027	0.0643	CbGbCtD
Hydrocodone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0205	0.0488	CbGbCtD
Hydrocodone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0196	0.0467	CbGbCtD
Hydrocodone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0196	0.0467	CbGbCtD
Hydrocodone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0185	0.0442	CbGbCtD
Hydrocodone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0138	0.0329	CbGbCtD
Hydrocodone—CYP3A4—Losartan—type 2 diabetes mellitus	0.0126	0.0301	CbGbCtD
Hydrocodone—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.000334	0.121	CrCbGaD
Hydrocodone—Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.000293	0.106	CrCbGaD
Hydrocodone—Ethylmorphine—CYP3A4—type 2 diabetes mellitus	0.00028	0.102	CrCbGaD
Hydrocodone—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000259	0.00115	CcSEcCtD
Hydrocodone—Cough—Orlistat—type 2 diabetes mellitus	0.000259	0.00115	CcSEcCtD
Hydrocodone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000259	0.00115	CcSEcCtD
Hydrocodone—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000259	0.00115	CcSEcCtD
Hydrocodone—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000258	0.00115	CcSEcCtD
Hydrocodone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000258	0.00115	CcSEcCtD
Hydrocodone—Convulsion—Orlistat—type 2 diabetes mellitus	0.000258	0.00115	CcSEcCtD
Hydrocodone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000257	0.00115	CcSEcCtD
Hydrocodone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000257	0.00115	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000257	0.00114	CcSEcCtD
Hydrocodone—Tremor—Metformin—type 2 diabetes mellitus	0.000257	0.00114	CcSEcCtD
Hydrocodone—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000256	0.00114	CcSEcCtD
Hydrocodone—Myalgia—Valsartan—type 2 diabetes mellitus	0.000256	0.00114	CcSEcCtD
Hydrocodone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000256	0.00114	CcSEcCtD
Hydrocodone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000255	0.00114	CcSEcCtD
Hydrocodone—Anxiety—Valsartan—type 2 diabetes mellitus	0.000255	0.00114	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000254	0.00113	CcSEcCtD
Hydrocodone—Angiopathy—Losartan—type 2 diabetes mellitus	0.000254	0.00113	CcSEcCtD
Hydrocodone—Myalgia—Orlistat—type 2 diabetes mellitus	0.000253	0.00113	CcSEcCtD
Hydrocodone—Anxiety—Orlistat—type 2 diabetes mellitus	0.000252	0.00112	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000251	0.00112	CcSEcCtD
Hydrocodone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Hydrocodone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Hydrocodone—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000249	0.00111	CcSEcCtD
Hydrocodone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000249	0.00111	CcSEcCtD
Hydrocodone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000247	0.0011	CcSEcCtD
Hydrocodone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000246	0.00109	CcSEcCtD
Hydrocodone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000245	0.00109	CcSEcCtD
Hydrocodone—Rash—Glipizide—type 2 diabetes mellitus	0.000244	0.00109	CcSEcCtD
Hydrocodone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000244	0.00108	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000243	0.00108	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000243	0.00108	CcSEcCtD
Hydrocodone—Headache—Glipizide—type 2 diabetes mellitus	0.000242	0.00108	CcSEcCtD
Hydrocodone—Tremor—Irbesartan—type 2 diabetes mellitus	0.000242	0.00108	CcSEcCtD
Hydrocodone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000242	0.00108	CcSEcCtD
Hydrocodone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000241	0.00107	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP2E1—type 2 diabetes mellitus	0.00024	0.0874	CrCbGaD
Hydrocodone—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00024	0.00107	CcSEcCtD
Hydrocodone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00024	0.00107	CcSEcCtD
Hydrocodone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000239	0.00106	CcSEcCtD
Hydrocodone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000238	0.00106	CcSEcCtD
Hydrocodone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000238	0.00106	CcSEcCtD
Hydrocodone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000238	0.00106	CcSEcCtD
Hydrocodone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00106	CcSEcCtD
Hydrocodone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000238	0.00106	CcSEcCtD
Hydrocodone—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000236	0.00105	CcSEcCtD
Hydrocodone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000236	0.00105	CcSEcCtD
Hydrocodone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000235	0.00105	CcSEcCtD
Hydrocodone—Back pain—Losartan—type 2 diabetes mellitus	0.000235	0.00105	CcSEcCtD
Hydrocodone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000235	0.00105	CcSEcCtD
Hydrocodone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000235	0.00104	CcSEcCtD
Hydrocodone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000234	0.00104	CcSEcCtD
Hydrocodone—Oxycodone—CYP3A4—type 2 diabetes mellitus	0.000234	0.0849	CrCbGaD
Hydrocodone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000234	0.00104	CcSEcCtD
Hydrocodone—Myalgia—Metformin—type 2 diabetes mellitus	0.000233	0.00104	CcSEcCtD
Hydrocodone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000232	0.00103	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000232	0.00103	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000231	0.00103	CcSEcCtD
Hydrocodone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00023	0.00103	CcSEcCtD
Hydrocodone—Nausea—Glipizide—type 2 diabetes mellitus	0.00023	0.00102	CcSEcCtD
Hydrocodone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000229	0.00102	CcSEcCtD
Hydrocodone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000229	0.00102	CcSEcCtD
Hydrocodone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00102	CcSEcCtD
Hydrocodone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000229	0.00102	CcSEcCtD
Hydrocodone—Tremor—Losartan—type 2 diabetes mellitus	0.000228	0.00101	CcSEcCtD
Hydrocodone—Rash—Glimepiride—type 2 diabetes mellitus	0.000228	0.00101	CcSEcCtD
Hydrocodone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000227	0.00101	CcSEcCtD
Hydrocodone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00101	CcSEcCtD
Hydrocodone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00101	CcSEcCtD
Hydrocodone—Headache—Glimepiride—type 2 diabetes mellitus	0.000226	0.00101	CcSEcCtD
Hydrocodone—Cough—Irbesartan—type 2 diabetes mellitus	0.000226	0.001	CcSEcCtD
Hydrocodone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000225	0.001	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000224	0.000995	CcSEcCtD
Hydrocodone—Codeine—CYP3A4—type 2 diabetes mellitus	0.000223	0.081	CrCbGaD
Hydrocodone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000222	0.000988	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000221	0.000984	CcSEcCtD
Hydrocodone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00022	0.000981	CcSEcCtD
Hydrocodone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00022	0.000979	CcSEcCtD
Hydrocodone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00022	0.000979	CcSEcCtD
Hydrocodone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000219	0.000976	CcSEcCtD
Hydrocodone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000219	0.000976	CcSEcCtD
Hydrocodone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000219	0.000976	CcSEcCtD
Hydrocodone—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000219	0.000976	CcSEcCtD
Hydrocodone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000219	0.000974	CcSEcCtD
Hydrocodone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000219	0.000974	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000219	0.000973	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000219	0.000972	CcSEcCtD
Hydrocodone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000218	0.000971	CcSEcCtD
Hydrocodone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000218	0.000969	CcSEcCtD
Hydrocodone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000217	0.000966	CcSEcCtD
Hydrocodone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000216	0.000962	CcSEcCtD
Hydrocodone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000216	0.000961	CcSEcCtD
Hydrocodone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000215	0.000958	CcSEcCtD
Hydrocodone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000215	0.000958	CcSEcCtD
Hydrocodone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000214	0.000954	CcSEcCtD
Hydrocodone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000214	0.000951	CcSEcCtD
Hydrocodone—Naloxone—CYP3A4—type 2 diabetes mellitus	0.000214	0.0777	CrCbGaD
Hydrocodone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000214	0.00095	CcSEcCtD
Hydrocodone—Cough—Losartan—type 2 diabetes mellitus	0.000212	0.000945	CcSEcCtD
Hydrocodone—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.000212	0.0771	CrCbGaD
Hydrocodone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000212	0.000943	CcSEcCtD
Hydrocodone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000212	0.000942	CcSEcCtD
Hydrocodone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000211	0.00094	CcSEcCtD
Hydrocodone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000211	0.00094	CcSEcCtD
Hydrocodone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000211	0.000937	CcSEcCtD
Hydrocodone—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00021	0.000934	CcSEcCtD
Hydrocodone—Constipation—Valsartan—type 2 diabetes mellitus	0.00021	0.000934	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000209	0.000932	CcSEcCtD
Hydrocodone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000209	0.000931	CcSEcCtD
Hydrocodone—Hypotension—Metformin—type 2 diabetes mellitus	0.000209	0.00093	CcSEcCtD
Hydrocodone—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000209	0.000928	CcSEcCtD
Hydrocodone—Arthralgia—Losartan—type 2 diabetes mellitus	0.000207	0.000922	CcSEcCtD
Hydrocodone—Myalgia—Losartan—type 2 diabetes mellitus	0.000207	0.000922	CcSEcCtD
Hydrocodone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000207	0.000921	CcSEcCtD
Hydrocodone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000207	0.000921	CcSEcCtD
Hydrocodone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000207	0.000919	CcSEcCtD
Hydrocodone—Anxiety—Losartan—type 2 diabetes mellitus	0.000206	0.000919	CcSEcCtD
Hydrocodone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000205	0.000913	CcSEcCtD
Hydrocodone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000205	0.000913	CcSEcCtD
Hydrocodone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000205	0.000912	CcSEcCtD
Hydrocodone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000204	0.000908	CcSEcCtD
Hydrocodone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000204	0.000908	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000204	0.000906	CcSEcCtD
Hydrocodone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000203	0.000901	CcSEcCtD
Hydrocodone—Galantamine—CYP3A4—type 2 diabetes mellitus	0.000202	0.0736	CrCbGaD
Hydrocodone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000201	0.000893	CcSEcCtD
Hydrocodone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000201	0.000893	CcSEcCtD
Hydrocodone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000201	0.000893	CcSEcCtD
Hydrocodone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000199	0.000887	CcSEcCtD
Hydrocodone—Somnolence—Metformin—type 2 diabetes mellitus	0.000199	0.000885	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000198	0.000883	CcSEcCtD
Hydrocodone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000197	0.000877	CcSEcCtD
Hydrocodone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000197	0.000876	CcSEcCtD
Hydrocodone—Tremor—Ramipril—type 2 diabetes mellitus	0.000195	0.00087	CcSEcCtD
Hydrocodone—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000195	0.000867	CcSEcCtD
Hydrocodone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000194	0.000865	CcSEcCtD
Hydrocodone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000194	0.000864	CcSEcCtD
Hydrocodone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000193	0.000861	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000193	0.000859	CcSEcCtD
Hydrocodone—Fatigue—Metformin—type 2 diabetes mellitus	0.000193	0.000858	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000192	0.000855	CcSEcCtD
Hydrocodone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000192	0.000854	CcSEcCtD
Hydrocodone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000192	0.000853	CcSEcCtD
Hydrocodone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000192	0.000853	CcSEcCtD
Hydrocodone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000192	0.000853	CcSEcCtD
Hydrocodone—Constipation—Metformin—type 2 diabetes mellitus	0.000191	0.000851	CcSEcCtD
Hydrocodone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000189	0.000843	CcSEcCtD
Hydrocodone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000189	0.000842	CcSEcCtD
Hydrocodone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000189	0.000841	CcSEcCtD
Hydrocodone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000188	0.000837	CcSEcCtD
Hydrocodone—Rash—Glyburide—type 2 diabetes mellitus	0.000188	0.000835	CcSEcCtD
Hydrocodone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000188	0.000835	CcSEcCtD
Hydrocodone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000187	0.000834	CcSEcCtD
Hydrocodone—Headache—Glyburide—type 2 diabetes mellitus	0.000186	0.00083	CcSEcCtD
Hydrocodone—Naloxone—ALB—type 2 diabetes mellitus	0.000186	0.0678	CrCbGaD
Hydrocodone—Hypotension—Losartan—type 2 diabetes mellitus	0.000186	0.000826	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000183	0.000814	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000182	0.000811	CcSEcCtD
Hydrocodone—Cough—Ramipril—type 2 diabetes mellitus	0.000182	0.00081	CcSEcCtD
Hydrocodone—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000182	0.00081	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000181	0.000805	CcSEcCtD
Hydrocodone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000181	0.000805	CcSEcCtD
Hydrocodone—Convulsion—Ramipril—type 2 diabetes mellitus	0.000181	0.000804	CcSEcCtD
Hydrocodone—Constipation—Irbesartan—type 2 diabetes mellitus	0.00018	0.000803	CcSEcCtD
Hydrocodone—Morphine—CYP3A4—type 2 diabetes mellitus	0.00018	0.0656	CrCbGaD
Hydrocodone—Insomnia—Losartan—type 2 diabetes mellitus	0.00018	0.000799	CcSEcCtD
Hydrocodone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000179	0.000795	CcSEcCtD
Hydrocodone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000178	0.000793	CcSEcCtD
Hydrocodone—Myalgia—Ramipril—type 2 diabetes mellitus	0.000178	0.00079	CcSEcCtD
Hydrocodone—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000178	0.00079	CcSEcCtD
Hydrocodone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000177	0.000788	CcSEcCtD
Hydrocodone—Anxiety—Ramipril—type 2 diabetes mellitus	0.000177	0.000788	CcSEcCtD
Hydrocodone—Nausea—Glyburide—type 2 diabetes mellitus	0.000177	0.000787	CcSEcCtD
Hydrocodone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000177	0.000787	CcSEcCtD
Hydrocodone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000177	0.000786	CcSEcCtD
Hydrocodone—Somnolence—Losartan—type 2 diabetes mellitus	0.000177	0.000786	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000176	0.000785	CcSEcCtD
Hydrocodone—Asthenia—Valsartan—type 2 diabetes mellitus	0.000176	0.000784	CcSEcCtD
Hydrocodone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000174	0.000775	CcSEcCtD
Hydrocodone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000174	0.000773	CcSEcCtD
Hydrocodone—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000174	0.000773	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000173	0.000768	CcSEcCtD
Hydrocodone—Pruritus—Orlistat—type 2 diabetes mellitus	0.000172	0.000764	CcSEcCtD
Hydrocodone—Fatigue—Losartan—type 2 diabetes mellitus	0.000171	0.000762	CcSEcCtD
Hydrocodone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00017	0.000756	CcSEcCtD
Hydrocodone—Constipation—Losartan—type 2 diabetes mellitus	0.00017	0.000756	CcSEcCtD
Hydrocodone—Rash—Gliclazide—type 2 diabetes mellitus	0.000168	0.00075	CcSEcCtD
Hydrocodone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000168	0.000749	CcSEcCtD
Hydrocodone—Headache—Gliclazide—type 2 diabetes mellitus	0.000167	0.000745	CcSEcCtD
Hydrocodone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000167	0.000743	CcSEcCtD
Hydrocodone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000167	0.000742	CcSEcCtD
Hydrocodone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000167	0.000742	CcSEcCtD
Hydrocodone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000167	0.000742	CcSEcCtD
Hydrocodone—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000165	0.000736	CcSEcCtD
Hydrocodone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000165	0.000732	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000162	0.000723	CcSEcCtD
Hydrocodone—Dizziness—Valsartan—type 2 diabetes mellitus	0.000162	0.000722	CcSEcCtD
Hydrocodone—Dizziness—Orlistat—type 2 diabetes mellitus	0.00016	0.000714	CcSEcCtD
Hydrocodone—Asthenia—Metformin—type 2 diabetes mellitus	0.00016	0.000714	CcSEcCtD
Hydrocodone—Hypotension—Ramipril—type 2 diabetes mellitus	0.000159	0.000708	CcSEcCtD
Hydrocodone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000159	0.000706	CcSEcCtD
Hydrocodone—Pruritus—Metformin—type 2 diabetes mellitus	0.000158	0.000704	CcSEcCtD
Hydrocodone—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000157	0.000699	CcSEcCtD
Hydrocodone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000157	0.000699	CcSEcCtD
Hydrocodone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000156	0.000695	CcSEcCtD
Hydrocodone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000155	0.000692	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000155	0.00069	CcSEcCtD
Hydrocodone—Rash—Valsartan—type 2 diabetes mellitus	0.000155	0.000689	CcSEcCtD
Hydrocodone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000155	0.000688	CcSEcCtD
Hydrocodone—Vomiting—Orlistat—type 2 diabetes mellitus	0.000154	0.000686	CcSEcCtD
Hydrocodone—Insomnia—Ramipril—type 2 diabetes mellitus	0.000154	0.000685	CcSEcCtD
Hydrocodone—Headache—Valsartan—type 2 diabetes mellitus	0.000154	0.000684	CcSEcCtD
Hydrocodone—Rash—Orlistat—type 2 diabetes mellitus	0.000153	0.000681	CcSEcCtD
Hydrocodone—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000153	0.00068	CcSEcCtD
Hydrocodone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000153	0.00068	CcSEcCtD
Hydrocodone—Headache—Orlistat—type 2 diabetes mellitus	0.000152	0.000676	CcSEcCtD
Hydrocodone—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000152	0.000675	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP3A4—type 2 diabetes mellitus	0.000151	0.0551	CrCbGaD
Hydrocodone—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000151	0.000674	CcSEcCtD
Hydrocodone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000151	0.000674	CcSEcCtD
Hydrocodone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000149	0.000664	CcSEcCtD
Hydrocodone—Dizziness—Metformin—type 2 diabetes mellitus	0.000148	0.000658	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000147	0.000654	CcSEcCtD
Hydrocodone—Fatigue—Ramipril—type 2 diabetes mellitus	0.000147	0.000653	CcSEcCtD
Hydrocodone—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000146	0.000651	CcSEcCtD
Hydrocodone—Nausea—Valsartan—type 2 diabetes mellitus	0.000146	0.000649	CcSEcCtD
Hydrocodone—Constipation—Ramipril—type 2 diabetes mellitus	0.000146	0.000648	CcSEcCtD
Hydrocodone—Nausea—Orlistat—type 2 diabetes mellitus	0.000144	0.000641	CcSEcCtD
Hydrocodone—Asthenia—Losartan—type 2 diabetes mellitus	0.000142	0.000634	CcSEcCtD
Hydrocodone—Vomiting—Metformin—type 2 diabetes mellitus	0.000142	0.000633	CcSEcCtD
Hydrocodone—Rash—Metformin—type 2 diabetes mellitus	0.000141	0.000627	CcSEcCtD
Hydrocodone—Dermatitis—Metformin—type 2 diabetes mellitus	0.000141	0.000627	CcSEcCtD
Hydrocodone—Pruritus—Losartan—type 2 diabetes mellitus	0.00014	0.000625	CcSEcCtD
Hydrocodone—Headache—Metformin—type 2 diabetes mellitus	0.00014	0.000623	CcSEcCtD
Hydrocodone—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00014	0.000621	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000139	0.00062	CcSEcCtD
Hydrocodone—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000135	0.000599	CcSEcCtD
Hydrocodone—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000135	0.000599	CcSEcCtD
Hydrocodone—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000134	0.000597	CcSEcCtD
Hydrocodone—Rash—Irbesartan—type 2 diabetes mellitus	0.000133	0.000592	CcSEcCtD
Hydrocodone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000133	0.000591	CcSEcCtD
Hydrocodone—Nausea—Metformin—type 2 diabetes mellitus	0.000133	0.000591	CcSEcCtD
Hydrocodone—Headache—Irbesartan—type 2 diabetes mellitus	0.000132	0.000588	CcSEcCtD
Hydrocodone—Dizziness—Losartan—type 2 diabetes mellitus	0.000131	0.000584	CcSEcCtD
Hydrocodone—Vomiting—Losartan—type 2 diabetes mellitus	0.000126	0.000562	CcSEcCtD
Hydrocodone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000125	0.000558	CcSEcCtD
Hydrocodone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000125	0.000558	CcSEcCtD
Hydrocodone—Rash—Losartan—type 2 diabetes mellitus	0.000125	0.000557	CcSEcCtD
Hydrocodone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000125	0.000557	CcSEcCtD
Hydrocodone—Headache—Losartan—type 2 diabetes mellitus	0.000124	0.000554	CcSEcCtD
Hydrocodone—Asthenia—Ramipril—type 2 diabetes mellitus	0.000122	0.000544	CcSEcCtD
Hydrocodone—Pruritus—Ramipril—type 2 diabetes mellitus	0.00012	0.000536	CcSEcCtD
Hydrocodone—Nausea—Losartan—type 2 diabetes mellitus	0.000118	0.000525	CcSEcCtD
Hydrocodone—Dizziness—Ramipril—type 2 diabetes mellitus	0.000113	0.000501	CcSEcCtD
Hydrocodone—Vomiting—Ramipril—type 2 diabetes mellitus	0.000108	0.000482	CcSEcCtD
Hydrocodone—Rash—Ramipril—type 2 diabetes mellitus	0.000107	0.000478	CcSEcCtD
Hydrocodone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000107	0.000477	CcSEcCtD
Hydrocodone—Headache—Ramipril—type 2 diabetes mellitus	0.000107	0.000475	CcSEcCtD
Hydrocodone—Nausea—Ramipril—type 2 diabetes mellitus	0.000101	0.00045	CcSEcCtD
Hydrocodone—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.69e-05	0.000238	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.69e-05	0.000238	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.68e-05	0.000236	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.68e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.67e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.67e-05	0.000235	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.65e-05	0.000232	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—C3—type 2 diabetes mellitus	1.64e-05	0.000231	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.63e-05	0.000229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.61e-05	0.000227	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.6e-05	0.000225	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.58e-05	0.000223	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.58e-05	0.000222	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.57e-05	0.00022	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.57e-05	0.00022	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.56e-05	0.00022	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.56e-05	0.000219	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.55e-05	0.000218	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.55e-05	0.000218	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.53e-05	0.000216	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.53e-05	0.000215	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.53e-05	0.000215	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.53e-05	0.000215	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.51e-05	0.000213	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.5e-05	0.000211	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.5e-05	0.000211	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.5e-05	0.00021	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.5e-05	0.00021	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.5e-05	0.00021	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.5e-05	0.00021	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.5e-05	0.00021	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.48e-05	0.000209	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.47e-05	0.000207	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.46e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.46e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.46e-05	0.000205	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.45e-05	0.000204	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.45e-05	0.000204	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.44e-05	0.000203	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—C3—type 2 diabetes mellitus	1.44e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.44e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.42e-05	0.000199	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.41e-05	0.000199	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.41e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.37e-05	0.000193	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.37e-05	0.000193	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.37e-05	0.000192	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.37e-05	0.000192	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.37e-05	0.000192	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.35e-05	0.00019	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.35e-05	0.000189	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.34e-05	0.000189	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.34e-05	0.000189	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.33e-05	0.000187	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.33e-05	0.000186	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.32e-05	0.000186	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.31e-05	0.000185	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	1.31e-05	0.000184	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.28e-05	0.000181	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.27e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.26e-05	0.000177	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.25e-05	0.000175	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.23e-05	0.000172	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.22e-05	0.000171	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.22e-05	0.000171	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.22e-05	0.000171	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.2e-05	0.000168	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.18e-05	0.000166	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.16e-05	0.000164	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.16e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.16e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.16e-05	0.000163	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.15e-05	0.000162	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.15e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.15e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	1.15e-05	0.000161	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.14e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.14e-05	0.00016	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.13e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.12e-05	0.000157	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.11e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.11e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.1e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.08e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.07e-05	0.00015	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.07e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.01e-05	0.000142	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1e-05	0.000141	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.98e-06	0.00014	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.81e-06	0.000138	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.72e-06	0.000137	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	9.68e-06	0.000136	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.66e-06	0.000136	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.64e-06	0.000136	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.64e-06	0.000136	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.64e-06	0.000136	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.64e-06	0.000136	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	9.61e-06	0.000135	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.52e-06	0.000134	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	9.5e-06	0.000134	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	9.5e-06	0.000134	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.45e-06	0.000133	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.36e-06	0.000132	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.35e-06	0.000132	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.31e-06	0.000131	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	9.26e-06	0.00013	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.24e-06	0.00013	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.19e-06	0.000129	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	9.11e-06	0.000128	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	9.11e-06	0.000128	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.09e-06	0.000128	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.91e-06	0.000125	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.89e-06	0.000125	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.61e-06	0.000121	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.59e-06	0.000121	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.53e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.49e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.49e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.47e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.47e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.25e-06	0.000116	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.06e-06	0.000113	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.02e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.99e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.97e-06	0.000112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.86e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.86e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.85e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.85e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.81e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.81e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.71e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.7e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.66e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.66e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.66e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.61e-06	0.000107	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.57e-06	0.000106	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	7.48e-06	0.000105	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.47e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.43e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.43e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.39e-06	0.000104	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	7.28e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.27e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.23e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.21e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.16e-06	0.000101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	7.15e-06	0.0001	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	7e-06	9.84e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.97e-06	9.8e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.87e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.87e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.87e-06	9.66e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.81e-06	9.58e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.79e-06	9.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.74e-06	9.48e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.74e-06	9.47e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.7e-06	9.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.68e-06	9.39e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.64e-06	9.34e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.6e-06	9.29e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.54e-06	9.19e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.51e-06	9.16e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	6.43e-06	9.05e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	6.31e-06	8.88e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.28e-06	8.83e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.28e-06	8.83e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.21e-06	8.73e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.21e-06	8.73e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.11e-06	8.6e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	6.11e-06	8.6e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.01e-06	8.45e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.99e-06	8.42e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.95e-06	8.37e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.95e-06	8.37e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.92e-06	8.33e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.71e-06	8.02e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.61e-06	7.89e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.5e-06	7.74e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.26e-06	7.4e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.22e-06	7.34e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.13e-06	7.22e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.13e-06	7.22e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.12e-06	7.2e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.11e-06	7.18e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.04e-06	7.09e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	5e-06	7.04e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.89e-06	6.88e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.76e-06	6.69e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.69e-06	6.6e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.67e-06	6.57e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.62e-06	6.49e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.57e-06	6.43e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.56e-06	6.41e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.49e-06	6.31e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.49e-06	6.31e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.44e-06	6.24e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.38e-06	6.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.23e-06	5.95e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.21e-06	5.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.13e-06	5.8e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.1e-06	5.77e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4e-06	5.62e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.93e-06	5.53e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.92e-06	5.51e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.9e-06	5.49e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.87e-06	5.44e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.41e-06	4.8e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.35e-06	4.7e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.07e-06	4.31e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.93e-06	4.13e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.93e-06	4.13e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.68e-06	3.77e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.06e-06	2.9e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.35e-06	1.9e-05	CbGpPWpGaD
